Health New Zealand

Influenza Antivirals for the National Reserve Supply (NRS) in New Zealand

This RFQ issued by Health New Zealand - Te Whatu Ora (Health NZ), is an invitation to suppliers to submit a quote to provide approximately 263,200 courses of influenza antivirals to replenish the expiring stock in our National Reserve Supply (NRS) in New Zealand.

The current influenza antiviral stock is Oseltamivir (Tamiflu®) from Roche & Zanamivir (Relenza Rotadisk) from GSK. Health NZ has a requirement to hold influenza antivirals for possible emergency response. We currently have a requirement to replace expiring stock within our holdings. Where new brands of influenza antivirals are awarded, approval from Medsafe must be sought and approved within six months of the contract being awarded.

Health NZ is seeking to appoint one supplier for this one-off purchase. A consortium bid may be considered; however, the consortium must identify the lead provider accountable for delivery and who will be the counterparty to Health NZ’s contract.

Department/Business Unit: National Procurement